NEW YORK (TheStreet) -- RATINGS CHANGES
(AA - Get Report) was upgraded at RBC Capital to sector perform from underperform. Twelve-month price target is $15. Performance in the alumina business and GRP has been stronger than expected, RBC Capital said.
(AU) was downgraded to sell at TheStreet Ratings.
Bank of America
(BAC - Get Report) was upgraded at Oppenheimer to outperform from perform. Twelve-month price target is $19. Future legal costs appear to be finite and manageable, Oppenheimer said.
was upgraded at Sterne Agee to buy from neutral. Twelve-month price target is $92. H&R Block
deal should be solidly accretive to earnings, Sterne Agee said.
was downgraded to hold at TheStreet Ratings.
was upgraded at Jefferies to buy from hold. Valuation call based on 12-month price target of $64.50, Jefferies said.
Enterprise Products Partners
was downgraded at Jefferies to hold from buy. Valuation call on 12-month price target of $75, Jefferies said.
was upgraded at J.P. Morgan to overweight from neutral. Twelve-month price target is $28. Stock has pulled back 17% this month, and the company can continue to grow both overseas and abroad, J.P. Morgan said.
was downgraded at Leerink Swann to market perform from outperform. Twelve-month price target is $27. Company could face earlier generic competition for Angiomax, Leerink Swann said.
was downgraded at Citigroup to neutral from buy. Twelve-month price target is $48. Company is seeing multiple signs of a potential market slowdown, Citigroup said.